CRYTERION MEDICAL

Cryterion Medical has developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). Cryterion is headquartered in Carlsbad, California, with offices in Montreal, Canada and Wexford, Ireland. The Cryterion Medical cryoablation platform uses cryothermal energy to interrupt the irregular electrical signals that can cause AF. Developed with a next-generation balloon catheter, advanced mapping catheter, steerable sheath and enhanced console, the system is designed to streamline overall procedural workflow, enhance maneuverability and improve positioning in challenging anatomy.